ABBOTT INDIA
Back to Balance Sheet
|
ABBOTT INDIA Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹1,407 Cr | ₹1,343 Cr | ₹1,206 Cr | ₹1,203 Cr | ₹1,031 Cr |
What is the latest Total Current Liabilities ratio of ABBOTT INDIA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹1,407 Cr |
| Mar2024 | ₹1,343 Cr |
| Mar2023 | ₹1,206 Cr |
| Mar2022 | ₹1,203 Cr |
| Mar2021 | ₹1,031 Cr |
How is Total Current Liabilities of ABBOTT INDIA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,407 Cr | 4.80 | |
| Mar2024 | ₹1,343 Cr | 11.33 | |
| Mar2023 | ₹1,206 Cr | 0.24 | |
| Mar2022 | ₹1,203 Cr | 16.72 | |
| Mar2021 | ₹1,031 Cr | - | |
Compare Total Current Liabilities of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹55,056.0 Cr | 0.5% | -4.6% | -11.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,083.0 Cr | -1% | -7% | -1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,971.0 Cr | 5% | -2.7% | 15.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,660.0 Cr | 3.2% | -6.2% | 29.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,686.0 Cr | 2.3% | -8.1% | 13.5% | Stock Analytics | |
| CIPLA | ₹99,086.7 Cr | 0.9% | -7.8% | -12.5% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | 0.5% |
-4.6% |
-11.1% |
| SENSEX | 4.7% |
-0.1% |
3.6% |
You may also like the below Video Courses